![](\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2025\/09\/new-ai-tool-could-speed-skin-cancer-diagnoses__750.jpg\")
<\/p>\n<\/p>\n
The project to develop the technology was led by PhD researcher Tess Watt (Heriot-Watt University\/PA). <\/p>\n
Key Things to Know:<\/p>\n
AI in medicine shows promise for early disease detection, but clinical integration still faces ethical, technical, and operational barriers.
\n Edge AI tools, such as low-cost diagnostic systems, reduce reliance on cloud infrastructure and protect patient privacy.
\n Skin cancer diagnosis is a leading use case for embedded AI, highlighting the importance of early intervention in improving survival rates.
\n Clinical validation, regulatory approval, and diverse training datasets remain essential for advancing trustworthy AI healthcare solutions.<\/p>\n
Artificial intelligence is already proving valuable in a range of medical applications, from improving diagnostic imaging to supporting early detection of disease. However, the clinical integration of AI is still in its early stages. While development continues to accelerate, significant technical, ethical, and operational barriers remain.<\/p>\n
What are the core challenges preventing widespread adoption? Why is medical data so difficult to access, and how do privacy concerns shape system design? More importantly, how close are we to real-world AI tools that can assist \u2014 not replace \u2014 medical professionals?<\/p>\n
The Challenges of AI in Medicine<\/p>\n
I’ve said it before, and I’ll keep saying it: AI needs to enter medicine\u00a0and fast.<\/p>\n
Why? Because the potential benefits are staggering, if not obscene. From spotting anomalies in radiology scans to predicting genetic disorders before symptoms emerge, AI brings accuracy, speed, and the holy grail of healthcare, early detection. And we know that early detection is the difference between manageable treatment and life-altering disease. AI could take that to a whole new level.<\/p>\n
But like most things in tech, it’s not that simple.<\/p>\n
For all its promise,\u00a0AI in medicine faces serious roadblocks<\/a>. The first and most obvious one is data. AI thrives on data, thousands or even millions of examples to learn from. However, medical data is hard to find, as it is locked behind layers of privacy legislation, ethical standards, and institutional red tape. And rightly so, as many would not want their MRI scans showing up in a training set without consent.<\/p>\n Then comes the problem of testing. It’s one thing to develop a promising diagnostic model in a lab; it’s a very different\u00a0thing\u00a0to run it in a hospital where real patients are on the line. There’s no sandbox mode when\u00a0you’re\u00a0dealing with human lives, making real-world validation ethically challenging, legally risky, and painfully slow.<\/p>\n And for all the benefits that AI presents, it will make mistakes. Especially in its early stages, even a 1% error rate can have\u00a0huge\u00a0consequences when\u00a0you’re\u00a0dealing with diagnoses, prescriptions, or surgical recommendations. The stakes are high, and medicine is not an industry where “move fast and break things” is tolerated.<\/p>\n Then there’s the human factor: resistance. Many medical professionals are sceptical of AI technology, with some fearing it will be replaced, while others simply don’t trust black-box systems when making life-or-death decisions.\u00a0<\/p>\n Combining data scarcity, ethical complexity, operational risk, and cultural resistance\u00a0to\u00a0medical AI<\/a>, it’s no surprise that AI hasn’t taken over hospitals yet.<\/p>\n Edge AI and Skin Cancer: A Glimpse at the Future of Remote Diagnosis<\/p>\n If there was ever a compelling case for embedded AI in healthcare, then the development of a new AI system capable of running in remote regions of the world,\u00a0identifying skin cancer early on,\u00a0would certainly be it.<\/p>\n At Heriot-Watt University in Scotland, PhD researcher Tess Watt has developed a low-cost, offline\u00a0diagnostic tool that uses artificial intelligence<\/a>\u00a0to identify potential skin cancers. Running on a Raspberry Pi requires no cloud backend, no internet connection, and no waiting for lab results.\u00a0This development is an excellent example of AI at the edge,\u00a0and\u00a0it could\u00a0potentially\u00a0change the way\u00a0rural communities access healthcare.<\/p>\n Why Early Detection with Edge AI Matters<\/p>\n The study highlights that skin cancer remains one of the most common cancers worldwide, with early intervention being critical for survival rates. By embedding AI directly into portable systems, researchers can bypass many of the infrastructure limitations that traditionally delay diagnosis. As the MDPI research notes, such solutions are not only affordable but also scalable, meaning they could serve as an accessible first-line diagnostic option in low-resource environments.<\/p>\n To use the device, a patient\u00a0uses\u00a0a basic camera module connected to a Raspberry Pi\u00a0to take a photo of a skin lesion.\u00a0The device then runs local inference using an image classification model trained on thousands of known dermatological cases. In seconds, it outputs a preliminary diagnosis.\u00a0That result can be passed to a local healthcare provider, if one is available,\u00a0for further review and treatment planning.<\/p>\n Importantly, the diagnostic model tested by Watt and colleagues was trained using publicly available dermatological image datasets, ensuring reproducibility and transparency in its development. According to the MDPI paper, leveraging open datasets is vital for increasing trust in AI medical tools, particularly when addressing regulatory requirements and ethical concerns around patient data use.<\/p>\n In this design, there is no upload, no data leakage, and no latency.\u00a0<\/p>\n Privacy Advantages of Offline Diagnostics<\/p>\n Data privacy remains one of the central barriers to medical AI adoption. By running entirely offline, edge devices mitigate risks associated with patient confidentiality breaches. The MDPI research stresses that reducing reliance on external servers is particularly important in maintaining compliance with data protection standards, an issue that continues to challenge cloud-based healthcare platforms.<\/p>\n Now,\u00a0the device is not perfect, with Watts’ team reporting about 85% diagnostic accuracy, but this is still impressive for an early-stage, edge-deployed model.\u00a0This device is the sort of prototype that signals what’s truly possible with medical AI and edge devices.\u00a0With improved datasets, better onboard models, and regulatory clearance,\u00a0a\u00a0system\u00a0like this\u00a0could provide life-saving diagnoses where dermatologists are miles or even continents away.<\/p>\n Improving Accuracy and Addressing Bias<\/p>\n The paper also identifies that while current models reach around 85% diagnostic accuracy, further improvements depend on the diversity of training data. Skin tones, lesion types, and imaging conditions all influence model robustness. Addressing these gaps will be essential to ensure that AI-assisted tools serve global populations equitably rather than reinforcing existing biases in healthcare systems.<\/p>\n Of course, there’s still a long road ahead. Clinical validation, regulatory approval, and scaling this for actual deployment take time.\u00a0But as Watt points out, the key is starting now,\u00a0because the longer we wait, the more people go diagnosed.<\/p>\n As the authors of the MDPI study underline, clinical validation will ultimately determine whether these devices can move beyond prototype stage. Integrating AI-driven diagnostics into established healthcare pathways requires collaboration between technologists, clinicians, and regulators. If these partnerships succeed, edge AI could become a cornerstone of community-level screening programmes, offering earlier intervention and reducing the burden on overstretched hospital systems.<\/p>\n Are Edge AI Devices the Future of Medical Care?<\/p>\n Ask anyone working in AI and healthcare what the\u00a0biggest\u00a0barrier to adoption is, and chances are they’ll give you one word: privacy.<\/p>\n Right now, most medical AI tools rely on the cloud. That means sensitive patient data (images, vitals, records) is uploaded, stored, and analysed on remote servers, sometimes halfway across the world. Understandably, this makes patients and healthcare providers nervous. It opens the door to data breaches, surveillance concerns, and regulatory headaches that slow everything down.<\/p>\n But what if the AI didn’t need the cloud?<\/p>\n That’s the promise of Edge AI in medicine;\u00a0diagnostic tools that run locally<\/a>, on-site, without any internet connection required.\u00a0No\u00a0upload or third-party processing, just instant analysis, done on a small, inexpensive device sitting in a clinic, an ambulance, or even a patient’s home.<\/p>\n However, it’s not just about privacy\u00a0either,\u00a0it’s also about access and equality. A device that doesn’t rely on cloud infrastructure doesn’t require broadband. It can work just as well in a remote Scottish island as it can in a city hospital,\u00a0and this drastically lowers\u00a0the barrier to care, especially in\u00a0under-served\u00a0regions where seeing a specialist is either cost-prohibitive or logistically impossible.<\/p>\n